Alison D. Axtman

Statistics

Publications

Citations

960

H-Index

Active since

2017

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Oxford

Goethe University Frankfurt

Takeda (United States)

Universidade Estadual de Campinas (UNICAMP)

Alison D. Axtman is an author at University of North Carolina at Chapel Hill specializing in drug discovery, medicinal chemistry, and kinase inhibitors.

ORCID

Publications per year

2017–2024

Publications

Progress towards a public chemogenomic set for protein kinases and a call for contributions

David H. Drewry, Carrow I. Wells, David Andrews et al. · PLoS ONE · 2017 · 170 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +14

Development of a potent and selective chemical probe for the pleiotropic kinase CK2

Carrow I. Wells, David H. Drewry, Julie E. Pickett et al. · Cell chemical biology · 2021 · 112 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14

The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification

Carrow I. Wells, Hassan Al‐Ali, David Andrews et al. · International Journal of Molecular Sciences · 2021 · 110 citations · Full text

Pharmacy, Bioinformatics, Molecular Biology +9

WNT Activates the AAK1 Kinase to Promote Clathrin-Mediated Endocytosis of LRP6 and Establish a Negative Feedback Loop

Megan J. Agajanian, Matthew P. Walker, Alison D. Axtman et al. · Cell Reports · 2019 · 96 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1

Sam A. Jamieson, Zheng Ruan, Abigail E. Burgess et al. · Science Signaling · 2018 · 61 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

1–5 of 25